Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 8:04 pm Sale | 2024-12-31 | 13G | Zymeworks Inc. ZYME | Redmile Group LLC | 4,840,463 7.000% | -261,448 (-5.12%) | Filing History |
| 2025-02-14 8:03 pm Purchase | 2024-12-31 | 13G | Silence Therapeutics plc SLN | Redmile Group LLC | 7,197,951 5.100% | 7,197,951 (New Position) | Filing History |
| 2025-02-14 8:03 pm Purchase | 2024-12-31 | 13G | Scholar Rock Holding Corporation SRRK | Redmile Group LLC | 9,885,124 9.900% | 1,583,937 (+19.08%) | Filing History |
| 2025-02-14 8:02 pm Purchase | 2024-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Redmile Group LLC | 13,932,449 9.900% | 10,155,602 (+268.89%) | Filing History |
| 2025-02-14 8:01 pm Sale | 2024-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | Redmile Group LLC | 2,895,478 4.800% | -302,013 (-9.45%) | Filing History |
| 2025-02-14 8:01 pm Purchase | 2024-12-31 | 13G | Neurogene Inc. NGNE | Redmile Group LLC | 1,479,766 9.900% | 429,462 (+40.89%) | Filing History |
| 2025-02-14 8:00 pm Purchase | 2024-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Redmile Group LLC | 13,163,457 8.200% | 3,028,069 (+29.88%) | Filing History |
| 2025-02-14 8:00 pm Sale | 2024-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Redmile Group LLC | 14,184,495 4.600% | -1,191,702 (-7.75%) | Filing History |
| 2024-12-26 9:00 pm Purchase | 2024-12-20 | 13D | Fate Therapeutics, Inc. FATE | Redmile Group LLC | 17,816,634 14.900% | 197,539 (+1.12%) | Filing History |
| 2024-12-06 9:03 pm Sale | 2024-12-04 | 13D | Shattuck Labs, Inc. STTK | Redmile Group LLC | 5,624,960 11.800% | -39,932 (-0.70%) | Filing History |
| 2024-11-14 9:00 pm Sale | 2024-09-30 | 13G | Amicus Therapeutics, Inc. FOLD | Redmile Group LLC | 15,376,197 5.100% | -6,581,729 (-29.97%) | Filing History |
| 2024-11-14 9:00 pm Purchase | 2024-09-30 | 13G | Immunome, Inc. IMNM | Redmile Group LLC | 4,889,554 8.100% | 1,010,139 (+26.04%) | Filing History |
| 2024-11-14 9:00 pm Sale | 2024-09-30 | 13G | Krystal Biotech, Inc. KRYS | Redmile Group LLC | 810,245 2.800% | -922,944 (-53.25%) | Filing History |
| 2024-11-14 9:00 pm Purchase | 2024-09-30 | 13G | Pliant Therapeutics, Inc. PLRX | Redmile Group LLC | 3,197,491 5.300% | 500,843 (+18.57%) | Filing History |
| 2024-11-14 9:00 pm Purchase | 2024-09-30 | 13G | Scholar Rock Holding Corporation SRRK | Redmile Group LLC | 8,301,187 9.900% | 594,304 (+7.71%) | Filing History |
| 2024-11-14 9:00 pm Purchase | 2024-09-30 | 13G | Stoke Therapeutics, Inc. STOK | Redmile Group LLC | 4,713,509 9.000% | 2,088,003 (+79.53%) | Filing History |
| 2024-11-14 9:00 pm Sale | 2024-09-30 | 13G | Zymeworks Inc. ZYME | Redmile Group LLC | 5,101,911 7.200% | -688,319 (-11.89%) | Filing History |
| 2024-11-14 9:00 pm Purchase | 2024-09-30 | 13G | ADC Therapeutics SA ADCT | Redmile Group LLC | 15,669,217 16.200% | 340,900 (+2.22%) | Filing History |
| 2024-11-14 9:00 pm Purchase | 2024-09-30 | 13G | Nurix Therapeutics, Inc. NRIX | Redmile Group LLC | 6,970,307 9.900% | 1,948,421 (+38.80%) | Filing History |
| 2024-11-14 9:00 pm Purchase | 2024-09-30 | 13G | REGENXBIO Inc. RGNX | Redmile Group LLC | 4,942,312 9.900% | 1,181,622 (+31.42%) | Filing History |